KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Omega Healthcare Investors (OHI) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to 69.87%.

  • Omega Healthcare Investors' EBITDA Margin rose 76200.0% to 69.87% in Q4 2025 from the same period last year, while for Dec 2025 it was 70.54%, marking a year-over-year increase of 94300.0%. This contributed to the annual value of 70.54% for FY2025, which is 94300.0% up from last year.
  • Per Omega Healthcare Investors' latest filing, its EBITDA Margin stood at 69.87% for Q4 2025, which was up 76200.0% from 80.06% recorded in Q3 2025.
  • Omega Healthcare Investors' EBITDA Margin's 5-year high stood at 2313.08% during Q3 2021, with a 5-year trough of 36.78% in Q4 2021.
  • Moreover, its 5-year median value for EBITDA Margin was 63.31% (2023), whereas its average is 175.91%.
  • Per our database at Business Quant, Omega Healthcare Investors' EBITDA Margin surged by 23462000bps in 2021 and then crashed by -22461000bps in 2022.
  • Omega Healthcare Investors' EBITDA Margin (Quarter) stood at 36.78% in 2021, then skyrocketed by 100bps to 73.51% in 2022, then plummeted by -31bps to 50.67% in 2023, then grew by 23bps to 62.25% in 2024, then rose by 12bps to 69.87% in 2025.
  • Its EBITDA Margin stands at 69.87% for Q4 2025, versus 80.06% for Q3 2025 and 70.83% for Q2 2025.